story of the week
Fecal Microbiota Transplant Overcomes Resistance to Anti–PD-1 Therapy in Melanoma Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Science (New York, N.Y.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Fecal Microbiota Transplant Overcomes Resistance to Anti-PD-1 Therapy in Melanoma Patients
Science 2021 Feb 05;371(6529)595-602, D Davar, AK Dzutsev, JA McCulloch, RR Rodrigues, JM Chauvin, RM Morrison, RN Deblasio, C Menna, Q Ding, O Pagliano, B Zidi, S Zhang, JH Badger, M Vetizou, AM Cole, MR Fernandes, S Prescott, RGF Costa, AK Balaji, A Morgun, I Vujkovic-Cvijin, H Wang, AA Borhani, MB Schwartz, HM Dubner, SJ Ernst, A Rose, YG Najjar, Y Belkaid, JM Kirkwood, G Trinchieri, HM ZarourFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.